- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.09. | Working smarter: best practices for thermal modeling in cold chain packaging design | ||
| 15.09. | Reaching more patients: How AI and data drive better representation in clinical trials | ||
| 12.09. | Takeda poaches top Lilly exec; Maze soars on early PKU drug data | ||
| 12.09. | Ozempic for cancer? Signs point to potential benefits of GLP-1s in oncology | ||
| 11.09. | Prasad regains role as FDA's top doctor, scientist | ||
| 11.09. | Child dies in Capsida study of rare disease gene therapy | ||
| 11.09. | FDA shares guidance to drugmakers developing non-opioid pain medicines | ||
| 10.09. | FDA clears J&J's drug-device combo for bladder cancer | ||
| 10.09. | Kriya, Odyssey secure 'megarounds'; Amgen boosts R&D leadership | ||
| 10.09. | Novo Nordisk to lay off 9,000 workers in major restructuring | ||
| 10.09. | [Podcast] The Progress Profile: Alzheimer's Research in Focus | ||
| 09.09. | Lilly to give biotech startups access to AI tools | ||
| 09.09. | Novartis to gain heart drug in $1.4B deal for Tourmaline Bio | ||
| 09.09. | BioNTech says dual-acting lung cancer drug helped shrink tumors | ||
| 08.09. | A new class of sleep drugs draws Wall Street's attention | ||
| 08.09. | Pfizer, BioNTech showcase new data supporting COVID booster | ||
| 08.09. | New Summit data clouds approval pathway in lung cancer | ||
| 08.09. | Rapport shares double on better-than-expected seizure drug data | ||
| 08.09. | A UK biotech takes aim at Parkinson's, ALS by drugging mitochondria | ||
| 08.09. | Driving precision oncology development: Integrated biomarker testing solutions that deliver impact | ||
| 08.09. | How sponsors are staying ahead in the obesity trial landscape | ||
| 08.09. | Harnessing the power of AI to detect ATTR-CM | ||
| 05.09. | FDA to publish CRLs in real time; PEPFAR to distribute Gilead's Yeztugo | ||
| 05.09. | Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug | ||
| 04.09. | At Senate hearing, lawmakers express dissatisfaction with RFK Jr.'s vaccine moves |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .